[1]李 涛 李承晏.个体化管理缺血性卒中急性期的血压[J].卒中与神经疾病杂志,2015,22(05):257-258.[doi:10.3969/j.issn.1007-0478.2015.05.001]
点击复制

个体化管理缺血性卒中急性期的血压()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第22卷
期数:
2015年05期
页码:
257-258
栏目:
述评
出版日期:
2015-09-20

文章信息/Info

文章编号:
1007-0478(2015)05-0257-02
作者:
李 涛 李承晏
作者单位:430060 武汉大学人民医院神经内科[李 涛 李承晏(通信作者)]
DOI:
10.3969/j.issn.1007-0478.2015.05.001
文献标志码:
A

参考文献/References:


1 Rothwell PM. Blood pressure in acute stroke: which questions remain? The Lancet. 2015, 385(9968):582-585.
2 He J, Zhang Y, Xu, T,et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke. The CATIS randomized clinical trial. JAMA, 2014, 311: 479-489.
3 The ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke(ENOS): a partial-factorial randomised controlled trial. Lancet, 2015, 385: 617-628.
4 Jauch EC, Chair F, Saver JL, et al. Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the american heart association/american stroke association. Stroke, 2013, 44:870-947.
5 Middleton S, Grimley R, Alexandrov AW, et al. Triage, treatment, and transfer: evidence-based clinical practice recommendations and models of nursing care for the f irst 72 hours of admission to hospital for acute stroke. Stroke, 2015, 46(2):e18-25.
6 Sandset, EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke(SCAST): a randomised, placebo-controlled, double-blind trial. Lancet, 2011, 377: 741-750.
7 Potter JP, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke(CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol, 2009, 8: 48-56.
8 Robinson TG, Potter JF, Ford GA, et al. Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study(COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol, 2010, 9: 767-775.
9 Rordorf G, Cramer SC, Efird JT, et al. Pharmacological elevation of blood pressure in acute stroke. Stroke, 1997, 28(11):2133-2138.
10 Chalela JA, Dunn B, Todd JW, et al. Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology, 2005, 64(11):1979.11 Koenig MA, Geocadin RG, Grouchy MD, et al. Safety of Induced Hypertension Therapy in Patients With Acute Ischemic Stroke. Neurocrit. Care,2006,4:3-7.
12 Shah QA, Patel S, Qureshi AI. Induced Hypertension in Patients With Partial Recanalization After Intra-arterial Thrombolysis for Acute Ischemic Stroke. J Neurosurg Anesthesiol, 2008, 20(2):154-155.
13 Gould B, McCourt R, Gioia LC,et al. Acute blood pressure reduction in patients with intracerebral hemorrhage does not result in borderzone region hypoperfusion. Stroke, 2014, 45(10):2894-2899.
14 Steiner T, Salman RAI, Beer R, et al. European Stroke Organisation(ESO)guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke, 2014, 9(7):840-855.
15 Wang YL, Xu J, Zhao XQ, et al. Association of Hypertension With Stroke Recurrence Depends on Ischemic Stroke Subtype. Stroke, 2013, 44:1232-1237.

备注/Memo

备注/Memo:
2015-04-28收稿
更新日期/Last Update: 2015-09-20